The Athlete-Blood Clot Connection
Clots commonly happen because of injuries, and the physicality of sports may increase a player’s risk.
Category: Hematology
‘Conversations with Innovators:’ UNC hematologist on promising drug...
Kenneth Ataga, MD, director of the UNC Comprehensive Sickle Cell Program, was featured in a video by the American Society of Hematology in which he discussed the favorable results of a yearlong clinical trial studying crizanlizumab as a therapy to prevent and treat painful crisis events in patients with sickle cell disease.
UNC researchers campaign for new funding to treat VTE
UNC’s Nigel Key and Alisa Wolberg labs were featured in a recent video produced by the American Society of Hematology to urge continued National Institutes of Health support for ongoing research of venous thromboembolism and other hematologic conditions.
UNC research helps answer why genetic mutation leads to decreased t...
Doctoral student Cassandra Hayne, working with Saskia Naher, PhD, found that a specific mutated version of a lipoprotein binds more effectively to liver cells, thus explaining decreased levels of triglycerides in blood.
On target: UNC researcher arms platelets to deliver cancer immunoth...
UNC, NCSU biomedical engineering research team’s findings show that engineered platelets can deliver antibodies to kill cancer cells before they can grow or spread elsewhere in the body.
The Unintended Consequences of Centralized Blood Banking and What T...
According to Anthony Charles, MD, MPH, of the UNC School of Medicine, the WHO should amend its centralization policy to help doctors save lives in Sub-Saharan Africa.
Can a smart patch prevent blood clots?
In lab experiments, North Carolina researchers developed the first patch to monitor blood viscosity and release blood thinning medication as needed.
High up-front costs could delay access to life-saving blood cancer ...
In the study published in the Journal of Clinical Oncology, UNC Lineberger researchers report that nearly a third of a group of patients with chronic myeloid leukemia, and who have federally-funded Medicare health insurance, did not start treatment within six months of diagnosis with any of three targeted drugs that have led to dramatic improvements in survival for the disease.
Spangler honored as ‘Sepsis Hero’ by Sepsis Alliance
On Thursday, Sept. 15, 2016, Sepsis Alliance held its fifth annual Sepsis Heroes: Celebrating Champions of Sepsis Awareness gala in New York City. UNC medical student Hillary Spangler was one of five honorees recognized as a Sepsis Hero. This annual event celebrates and applauds the work of individuals and organizations that have made great strides in raising sepsis awareness.
Blood clots and cancer: UNC professor identifies research prioritie...
Nigel Key, director of the UNC Hemophilia and Thrombosis Center, led a national initiative to prioritize research in studying the prevalence and mechanisms of venous thrombosis in cancer patients.
Risk of death for adults with blood cancer higher in three N.C. reg...
UNC Lineberger researchers led by Dr. William A. Wood found that for patients treated in a hospital, the risk of death from acute myeloid leukemia was elevated in three regions of the state compared to a benchmark.
Researchers discover how faulty genetic instructions drive a deadly...
A study by UNC Lineberger researcher G. Greg Wang, PhD, and colleagues uncovered the genetic mechanism for how acute myeloid leukemia cells with a specific DNA mutation stay as undifferentiated cells, rather than maturing into healthy blood cells.